Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cigna Corp (NY: CI )

350.30 -0.20 (-0.06%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cigna Corp

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Value Trap Or Opportunity?
A stock with a lower-than-usual price that appears to be a value stock but is not. A value trap appears to be undervalued at first glance but its fundamentals are unhealthy and the stock is unlikely to... 
Via Talk Markets
Leading Medical Professionals Launch Rappore, An Integrated Patient-Centric Mental Health Platform
A World-Class, Comprehensive, Digital Approach Democratizing Mental Health Care 
Via News Direct
Analyst Ratings For Cigna
Within the last quarter, Cigna (NYSE:CI) has observed the following analyst rat... 
Via Benzinga
Cigna Has Limited Visibility, No Bullish Catalysts, BofA Says In Double Downgrade
Cigna Corp (NYSE:CI) shares were losing ground Friday aft... 
Via Benzinga
8 Health Care Stocks With Unusual Options Alerts In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
Cigna – Too Cheap to Ignore
The company has started paying a dividend which would further add to the opportunity to now invest in this stock now that it’s undervalued. 
Via Talk Markets
Where Cigna Stands With Analysts
Analysts have provided the following ratings for Cigna (NYSE:CI) within the la... 
Via Benzinga
What 9 Analyst Ratings Have To Say About Cigna
Cigna (NYSE:CI) has observed the following analyst ratings within the last qua... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
Upgrades According to JonesTrading, the prior rating for Orchid Island Capital Inc (NYSE: 
Via Benzinga
5 Value Stocks In The Healthcare Sector
The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E... 
Via Benzinga
The Past Week's Notable Insider Buys: ConocoPhillips, Cricut, Energy Transfer And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some energy companies, including a supermajor, have seen... 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
Cigna Corporation (CI) Q2 2021 Earnings Call Transcript
CI earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Delta, Lambda Covid Variants Still Weighing On Market Despite Positive Earnings Reports
The market is still in a waiting mode, with a lot hinging on tomorrow’s jobs report. Predictions of a volatile, choppy week in the equity markets did not disappoint on... 
Via Benzinga
Cigna Strongly Beats On Q2 Earnings; Raises FY21 Sales Outlook, Expects Higher Unfavorable COVID-19 Impact
Cigna Corp reports Q2 total revenues of $43.1 billion, +9.8% Y/Y, ahead of the consensus of $41.31 billion. 
Via Talk Markets
Exposures COVID-19
Cigna: Q2 Earnings Insights
Shares of Cigna (NYSE:CI) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 9.81% year over year to $5.24, which beat the... 
Via Benzinga
Cigna Strongly Beats On Q2 Earnings; Raises FY21 Sales Outlook, Expects Higher Unfavorable COVID-19 Impact
Cigna Corp (NYSE: CI) reports Q2 total revenues of $43.1 billion, +9.8% Y/Y, ahead of the consensus of $41.31 billion. Q2 adjusted EPS reached $5.24 compared with... 
Via Benzinga
Exposures COVID-19
A Peek Into The Markets: US Stock Futures Up Ahead Of Jobless Claims Data
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones tumbled more than 300 points in the previous session. Investors are awaiting... 
Via Benzinga
Topics Stocks
Exposures US Equities
Another Big Earnings Week Ahead
After a monumental week of Big Tech earnings, we're in for more than a quarter of S&P 500 companies' reports, including those from Alibaba (NYSE: BABA), General Motors... 
Via Benzinga
Topics Stocks
Exposures US Equities
Price To Earnings Ratio Insights For Cigna
Right now, Cigna Inc. (NYSE:CI) share price is at $229.55, after a 0.1% increase. Moreover, over the past month, the stock fell by 2.41%, but in the past year, went... 
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
On One-Year Anniversary of ATLAS® Launch, 40 Percent of US Population Will Soon be in a State with Access to Free, Transparent Information on Addiction Treatment Quality
Shatterproof Expands to The State of California with Free Tool to Help Individuals and Families Find Trusted and High-Quality Addiction Treatment, Coming in 2022 
Via News Direct
Topics Death
Exposures COVID-19 Death
3 Top Value Stocks To Buy For July
It is becoming progressively more difficult to find true value stocks. Given the growth prospects of Molina Healthcare (MOH), AGCO Corporation (AGCO), and Lumber Liquidators (LL), their stocks still... 
Via Talk Markets
Biogen's Costly Alzheimer's Treatment May Face Restricted Medicare Access: WSJ
The recent approval of Biogen Inc's (NASDAQ: BIIB) high-price Alzheimer's drug is raising questions about who will have access to the $56,000/year... 
Via Benzinga
Biogen's Alzheimer's Drug Deals With CVS and Cigna: What Investors Should Know
One of these agreements could be more important than the other. 
Via The Motley Fool
3 Stocks to Buy After Recent Changes to Medicare
A cheaper approach could leave more money in the pockets of patients and shareholders. 
Via The Motley Fool
Biogen's New Alzheimer's Drug Will Cost $56,000 Per Year
Biogen set the list price for Aduhelm, its newly approved treatment, and is collaborating with CVS to improve screening for the disease. 
Via The Motley Fool
Oscar Vs. Cigna: Which Health Insurance Stock Is A Better Buy?
By providing virtual health support and low-cost medical expenditures, well known insurance companies Cigna and Oscar Health are well-positioned to capitalize on industry tailwinds as the demand for... 
Via Talk Markets
Will Health Insurers Start Competing With Teladoc?
Teladoc's amazing success in virtual healthcare has caused other healthcare companies to want to enter the market with their own solution. Even some insurance companies are getting in on the act. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
2 Bargain Stocks You Can Buy Right Now
Not only are they cheap, but they have some attractive growth prospects. 
Via The Motley Fool
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.